Abstract:Background: In 2020, the American College of Obstetricians and Gynecologists recommended noninvasive prenatal testing be offered to all patients. However, current societal guidelines in the United States do not universally recommend a detailed first-trimester ultrasound. Objective: This study aimed to determine the additional findings identified through first-trimester ultrasound that would have otherwise been missed if noninvasive prenatal testing was used alone as a first-trimester screening method. Study design: This was a retrospective cohort study involving 2158 pregnant patients and 2216 fetuses that were seen at a single medical center between January 1, 2020, and December 31, 2022. All those included underwent both noninvasive prenatal testing and detailed first-trimester ultrasound between 11.0 and 13.6 weeks of gestation. Noninvasive prenatal testing results were categorized as low risk or high risk, and first-trimester ultrasound results were categorized as normal or abnormal. Abnormal first-trimester ultrasounds were further classified as first-trimester screening markers (increased nuchal translucency, absent nasal bone, tricuspid regurgitation, and ductus venosus reverse a-wave) or structural defects (the cranium, neck, heart, thorax, abdominal wall, stomach, kidneys, bladder, spine, and extremities). Descriptive statistics were used to report our findings. Results: Of 2216 fetuses, 65 (3.0%) had a high-risk noninvasive prenatal testing result, whereas 2151 (97.0%) had a low-risk noninvasive prenatal testing result. Of those with a low-risk noninvasive prenatal testing result, 2035 (94.6%) had a normal first-trimester ultrasound, whereas 116 (5.4%) had at least 1 abnormal finding on first-trimester ultrasound. The most common screening marker detected within the low-risk noninvasive prenatal testing group was absent nasal bone (52/2151 [2.4%]), followed by reversed a-wave of the ductus venosus (30/2151 [1.4%]). The most common structural defect in this group was cardiac abnormality (15/2151 [0.7%]). Overall, 181 fetuses were identified as having "abnormal screening" through either a high-risk noninvasive prenatal testing result (n=65) or through a low-risk noninvasive prenatal testing result but abnormal first-trimester ultrasound (n=116). In summary, the incorporation of first-trimester ultrasound screening identified 116 additional fetuses (5.4%) that required further follow-up and surveillance than noninvasive prenatal testing alone would have identified. Conclusion: Detailed first-trimester ultrasound identified more fetuses with a potential abnormality than noninvasive prenatal testing alone. Therefore, first-trimester ultrasound remains a valuable screening method that should be used in combination with noninvasive prenatal testing.

Clinical value of standardized prenatal ultrasonography in diagnosis of twin abnormalities during early trimester

Clinical Value of Prenatal Ultrasonography in Diagnosis of Fetal Abnormalities in Fertilization-Embryo Transfer During Early Trimester

Clinical Value of Standardized Prenatal Ultrasonography in Diagnosis of Single Fetal Megacystis During Early Trimester

Combination prenatal ultrasound screening in early and middle stage of pregnancy for detecting fetal abnormalities

Diagnostic values of prenatal two-dimensional ultrasound and four-dimensional ultrasound for fetal spina bifida occulta

Clinical value of prenatal ultrasonography in diagnosis of multiple fetal megacystis during early trimester

Application Value of Fetal Heart Ultrasound Intelligent Navigation Technique in Display of Key Diagnostic Elements in Rapid Screening Views of Fetal Echocardiography

Clinical Value of Structural Screening by Ultrasound in Diagnosis of Fetal Central Nervous System Malformations at 11 ~ 13+6 Weeks of Gestation

The essentiality of prenatal ultrasound screening of fetal malformations in the first trimester

Clinical Value and Effectiveness of Sonography Screening for Fetal Chromosomal Abnormalities in the Middle and Late Pregnancy

Clinical value of standardized structural screening by ultrasound in diagnosis of fetal limbs malformations during the first trimester

Clinical Application of Ultrasound in Screening of Multiple Pregnancy and Selected Termination

Diagnosed value of ultrasonography in fetal central nervous system dysmorphosis during 11-13+6 weeks'gestation

Prenatal Ultrasound Diagnosis of Fetal Urinary System Abnormalities

Clinical Significance of Prenatal Ultrasonography for Detecting Birth Defects

The value of detailed first-trimester ultrasound in the era of noninvasive prenatal testing

The Value of Prenatal Ultrasonic Diagnosis in Conjoined Twins

The Value of Color Doppler Ultrasound in Screening Malformation of Prenatal

The Correlation for Prenatal Ultrasound Screening of Fetal Malformations and Fetal Chromosomal Abnormality

Preliminary discussion on high throughput sequencing of aneuploidy fetal chromosomal in twin pregnancy

[Noninvasive Prenatal Screening for Twin Pregnancy: an Analysis of 2057 Cases].